GSK1016790A
http://dbpedia.org/resource/GSK1016790A an entity of type: Thing
GSK1016790A (aka GSK101) is a drug developed by GlaxoSmithKline which acts as a potent and selective agonist for the TRPV4 receptor. It has been used to study the role of TRPV4 receptors in the function of smooth muscle tissue, particularly that lining blood vessels, lymphatic system, and the bladder.
rdf:langString
rdf:langString
GSK1016790A
xsd:integer
65319607
xsd:integer
1046769329
xsd:integer
28
xsd:integer
942206
xsd:integer
140524
xsd:integer
29310491
xsd:integer
2
xsd:integer
32
rdf:langString
N-[-1-[[4-[-2-[[sulfonyl]amino]-3-hydroxy-1-oxopropyl]-1-piperazinyl]carbonyl]-3-methylbutyl]benzo[b]thiophene-2-carboxamide
xsd:integer
4
xsd:integer
6
xsd:integer
23630211
xsd:integer
2
rdf:langString
CCC[C@H]C=O
xsd:integer
1
rdf:langString
IVYQPSHHYIAUFO-VXKWHMMOSA-N
xsd:integer
220
rdf:langString
GSK1016790A (aka GSK101) is a drug developed by GlaxoSmithKline which acts as a potent and selective agonist for the TRPV4 receptor. It has been used to study the role of TRPV4 receptors in the function of smooth muscle tissue, particularly that lining blood vessels, lymphatic system, and the bladder.
xsd:nonNegativeInteger
3651
xsd:string
942206-85-1
xsd:string
140524
xsd:string
23630211